DIAGNOS Inc. (DGNOF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.76 Million CAD | -21.36% |
| 2023 | 2.24 Million CAD | 15.79% |
| 2022 | 1.93 Million CAD | -16.66% |
| 2021 | 2.32 Million CAD | 7.02% |
| 2020 | 2.17 Million CAD | 0.0% |
| 2019 | 2.17 Million CAD | -21.28% |
| 2018 | 2.75 Million CAD | 2.38% |
| 2017 | 2.69 Million CAD | 6.89% |
| 2016 | 2.51 Million CAD | 18.48% |
| 2015 | 2.12 Million CAD | 0.77% |
| 2014 | 2.11 Million CAD | -17.09% |
| 2013 | 2.54 Million CAD | -19.13% |
| 2012 | 3.14 Million CAD | 18.27% |
| 2011 | 2.66 Million CAD | 16.5% |
| 2010 | 2.28 Million CAD | -43.49% |
| 2009 | 4.04 Million CAD | 76.5% |
| 2008 | 2.29 Million CAD | 50.64% |
| 2007 | 1.52 Million CAD | 17.07% |
| 2006 | 1.29 Million CAD | -32.0% |
| 2005 | 1.9 Million CAD | 284.49% |
| 2004 | 496.73 Thousand CAD | -44.77% |
| 2003 | 899.32 Thousand CAD | -70.63% |
| 2002 | 3.06 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 451.61 Thousand CAD | -5.54% |
| 2024 FY | 1.76 Million CAD | -21.36% |
| 2024 Q1 | 581.65 Thousand CAD | -24.07% |
| 2024 Q2 | 422.22 Thousand CAD | -27.41% |
| 2024 Q3 | 478.09 Thousand CAD | 13.23% |
| 2023 Q4 | 766.08 Thousand CAD | 90.75% |
| 2023 Q3 | 401.6 Thousand CAD | -4.88% |
| 2023 Q2 | 422.22 Thousand CAD | -26.62% |
| 2023 Q1 | 575.43 Thousand CAD | -24.89% |
| 2023 FY | 2.24 Million CAD | 15.79% |
| 2022 Q3 | 489.58 Thousand CAD | 22.0% |
| 2022 FY | 1.93 Million CAD | -16.66% |
| 2022 Q2 | 401.29 Thousand CAD | -33.3% |
| 2022 Q1 | 601.61 Thousand CAD | 16.41% |
| 2022 Q4 | 766.08 Thousand CAD | 56.48% |
| 2021 Q3 | 482.58 Thousand CAD | 13.84% |
| 2021 Q2 | 423.92 Thousand CAD | -17.3% |
| 2021 FY | 2.32 Million CAD | 7.02% |
| 2021 Q1 | 512.58 Thousand CAD | -46.71% |
| 2021 Q4 | 516.78 Thousand CAD | 7.09% |
| 2020 Q4 | 961.91 Thousand CAD | 120.61% |
| 2020 FY | 2.17 Million CAD | 0.0% |
| 2020 Q2 | 428.36 Thousand CAD | -13.74% |
| 2020 Q3 | 436.02 Thousand CAD | 1.79% |
| 2020 Q1 | 496.58 Thousand CAD | 6.33% |
| 2019 FY | 2.17 Million CAD | -21.28% |
| 2019 Q3 | 573.48 Thousand CAD | -5.26% |
| 2019 Q1 | 524.74 Thousand CAD | 30.5% |
| 2019 Q2 | 605.35 Thousand CAD | 15.36% |
| 2019 Q4 | 467.01 Thousand CAD | -18.57% |
| 2018 Q2 | 548.3 Thousand CAD | -41.86% |
| 2018 Q4 | 402.09 Thousand CAD | -53.46% |
| 2018 FY | 2.75 Million CAD | 2.38% |
| 2018 Q3 | 864.06 Thousand CAD | 57.59% |
| 2018 Q1 | 943.01 Thousand CAD | 14.82% |
| 2017 Q4 | 821.31 Thousand CAD | 9.0% |
| 2017 Q1 | 485.65 Thousand CAD | 6.35% |
| 2017 Q2 | 632.77 Thousand CAD | 30.29% |
| 2017 FY | 2.69 Million CAD | 6.89% |
| 2017 Q3 | 753.52 Thousand CAD | 19.08% |
| 2016 Q4 | 456.66 Thousand CAD | -25.93% |
| 2016 FY | 2.51 Million CAD | 18.48% |
| 2016 Q3 | 616.52 Thousand CAD | -28.52% |
| 2016 Q2 | 862.53 Thousand CAD | 47.7% |
| 2016 Q1 | 583.98 Thousand CAD | 15.42% |
| 2015 Q2 | 586.48 Thousand CAD | 18.78% |
| 2015 FY | 2.12 Million CAD | 0.77% |
| 2015 Q1 | 493.77 Thousand CAD | 10.94% |
| 2015 Q4 | 505.95 Thousand CAD | -6.4% |
| 2015 Q3 | 540.54 Thousand CAD | -7.83% |
| 2014 Q2 | 659.22 Thousand CAD | -12.7% |
| 2014 FY | 2.11 Million CAD | -17.09% |
| 2014 Q4 | 445.08 Thousand CAD | -21.24% |
| 2014 Q3 | 565.07 Thousand CAD | -14.28% |
| 2014 Q1 | 755.13 Thousand CAD | 18.63% |
| 2013 FY | 2.54 Million CAD | -19.13% |
| 2013 Q4 | 636.53 Thousand CAD | -19.25% |
| 2013 Q3 | 788.32 Thousand CAD | 11.03% |
| 2013 Q2 | 709.97 Thousand CAD | -16.68% |
| 2013 Q1 | 852.09 Thousand CAD | 26.98% |
| 2012 Q4 | 671.02 Thousand CAD | -24.18% |
| 2012 Q2 | 746.24 Thousand CAD | -11.72% |
| 2012 Q3 | 885.01 Thousand CAD | 18.6% |
| 2012 FY | 3.14 Million CAD | 18.27% |
| 2012 Q1 | 845.33 Thousand CAD | -2.57% |
| 2011 Q4 | 867.62 Thousand CAD | 101.25% |
| 2011 Q3 | 431.12 Thousand CAD | -41.53% |
| 2011 Q2 | 737.35 Thousand CAD | 23.6% |
| 2011 Q1 | 596.54 Thousand CAD | 9.28% |
| 2011 FY | 2.66 Million CAD | 16.5% |
| 2010 Q1 | 578.95 Thousand CAD | -29.26% |
| 2010 FY | 2.28 Million CAD | -43.49% |
| 2010 Q3 | 586.65 Thousand CAD | 2.4% |
| 2010 Q4 | 545.86 Thousand CAD | -6.95% |
| 2010 Q2 | 572.88 Thousand CAD | -1.05% |
| 2009 Q1 | 945.17 Thousand CAD | 19.99% |
| 2009 FY | 4.04 Million CAD | 76.5% |
| 2009 Q4 | 818.38 Thousand CAD | -34.37% |
| 2009 Q3 | 1.24 Million CAD | 24.99% |
| 2009 Q2 | 997.6 Thousand CAD | 5.55% |
| 2008 Q2 | 344.64 Thousand CAD | -23.08% |
| 2008 Q1 | 448.05 Thousand CAD | 22.79% |
| 2008 FY | 2.29 Million CAD | 50.64% |
| 2008 Q4 | 787.71 Thousand CAD | 10.97% |
| 2008 Q3 | 709.82 Thousand CAD | 105.96% |
| 2007 Q1 | 387.89 Thousand CAD | 15.19% |
| 2007 Q2 | 458.44 Thousand CAD | 18.19% |
| 2007 Q3 | 359.95 Thousand CAD | -21.48% |
| 2007 Q4 | 364.9 Thousand CAD | 1.38% |
| 2007 FY | 1.52 Million CAD | 17.07% |
| 2006 Q1 | 260.73 Thousand CAD | -27.91% |
| 2006 Q3 | 387.87 Thousand CAD | 23.79% |
| 2006 Q4 | 336.74 Thousand CAD | -13.18% |
| 2006 Q2 | 313.32 Thousand CAD | 20.17% |
| 2006 FY | 1.29 Million CAD | -32.0% |
| 2005 Q1 | 515.99 Thousand CAD | 319.06% |
| 2005 Q4 | 361.7 Thousand CAD | -21.92% |
| 2005 Q3 | 463.23 Thousand CAD | -15.48% |
| 2005 Q2 | 548.06 Thousand CAD | 6.22% |
| 2005 FY | 1.9 Million CAD | 284.49% |
| 2004 Q4 | 123.13 Thousand CAD | -17.41% |
| 2004 FY | 496.73 Thousand CAD | -44.77% |
| 2004 Q3 | 149.08 Thousand CAD | 36.41% |
| 2004 Q1 | 115.92 Thousand CAD | -50.69% |
| 2004 Q2 | 109.28 Thousand CAD | -5.72% |
| 2003 Q3 | 248.8 Thousand CAD | 46.24% |
| 2003 Q4 | 235.09 Thousand CAD | -5.51% |
| 2003 FY | 899.32 Thousand CAD | -70.63% |
| 2003 Q2 | 170.13 Thousand CAD | -43.78% |
| 2003 Q1 | 302.59 Thousand CAD | 0.0% |
| 2002 FY | 3.06 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Achiko AG | 6.78 Million USD | 74.019% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.04 Million USD | 78.081% |
| Cannabis Sativa, Inc. | 862.24 Thousand USD | -104.452% |
| CompuMed, Inc. | 2.91 Million USD | 39.573% |
| CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 99.825% |
| Cogstate Limited | 23.64 Million USD | 92.543% |
| CareView Communications, Inc. | 7.21 Million USD | 75.581% |
| Craneware plc | 141.35 Million USD | 98.753% |
| Caduceus Software Systems Corp. | 2.07 Million USD | 15.219% |
| Certive Solutions Inc. | 1.5 Million USD | -16.854% |
| Drug Free Solution, Inc. | 1.39 Million USD | -26.305% |
| DATATRAK International, Inc. | 3.26 Million USD | 46.065% |
| Strainsforpains, Inc. | 149.72 Thousand USD | -1077.425% |
| Healixa Inc. | 6.56 Million USD | 73.144% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 3.28 Million USD | 46.268% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | -150.792% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 491.28 USD | -358733.252% |
| iCoreConnect Inc. | 15.12 Million USD | 88.344% |
| IQ-AI Limited | 1.13 Million USD | -55.828% |
| Cannabiz Mobile, Inc. | 750.00 USD | -234950.133% |
| Mednow Inc. | 2.78 Million USD | 36.664% |
| Galileo Life Sciences, Inc. | 270.72 Thousand USD | -551.173% |
| MediXall Group, Inc. | 59.26 Thousand USD | -2874.415% |
| Mitesco, Inc. | 2.58 Million USD | 31.848% |
| MobileSmith, Inc. | 8.63 Million USD | 79.593% |
| NantHealth, Inc. | 94.47 Million USD | 98.134% |
| Net Medical Xpress Solutions, Inc. | 1.76 Million USD | -0.107% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 12.38 Million USD | 85.763% |
| Patient Access Solutions, Inc. | 9.19 Million USD | 80.824% |
| Pharma-Bio Serv, Inc. | 3.94 Million USD | 55.359% |
| PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | -1147.277% |
| Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -14368.779% |
| Renalytix Plc | 29.04 Million USD | 93.93% |
| Revium Recovery Inc. | 677 Thousand USD | -160.395% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 369.00 USD | -477644.173% |
| Vaso Corporation | 46.39 Million USD | 96.201% |
| Vynleads, Inc. | 200.15 Thousand USD | -780.751% |